1. Home
  2. ADIL vs AYRO Comparison

ADIL vs AYRO Comparison

Compare ADIL & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADIL
  • AYRO
  • Stock Information
  • Founded
  • ADIL 2010
  • AYRO 2017
  • Country
  • ADIL United States
  • AYRO United States
  • Employees
  • ADIL N/A
  • AYRO N/A
  • Industry
  • ADIL Biotechnology: Pharmaceutical Preparations
  • AYRO Telecommunications Equipment
  • Sector
  • ADIL Health Care
  • AYRO Consumer Discretionary
  • Exchange
  • ADIL Nasdaq
  • AYRO Nasdaq
  • Market Cap
  • ADIL 4.3M
  • AYRO 4.8M
  • IPO Year
  • ADIL 2018
  • AYRO N/A
  • Fundamental
  • Price
  • ADIL $0.60
  • AYRO $0.46
  • Analyst Decision
  • ADIL Strong Buy
  • AYRO
  • Analyst Count
  • ADIL 1
  • AYRO 0
  • Target Price
  • ADIL $8.00
  • AYRO N/A
  • AVG Volume (30 Days)
  • ADIL 72.0K
  • AYRO 96.5K
  • Earning Date
  • ADIL 05-13-2025
  • AYRO 05-14-2025
  • Dividend Yield
  • ADIL N/A
  • AYRO N/A
  • EPS Growth
  • ADIL N/A
  • AYRO N/A
  • EPS
  • ADIL N/A
  • AYRO N/A
  • Revenue
  • ADIL N/A
  • AYRO $63,777.00
  • Revenue This Year
  • ADIL N/A
  • AYRO N/A
  • Revenue Next Year
  • ADIL N/A
  • AYRO N/A
  • P/E Ratio
  • ADIL N/A
  • AYRO N/A
  • Revenue Growth
  • ADIL N/A
  • AYRO N/A
  • 52 Week Low
  • ADIL $0.61
  • AYRO $0.46
  • 52 Week High
  • ADIL $3.10
  • AYRO $1.64
  • Technical
  • Relative Strength Index (RSI)
  • ADIL 36.45
  • AYRO 36.36
  • Support Level
  • ADIL $0.67
  • AYRO $0.50
  • Resistance Level
  • ADIL $0.72
  • AYRO $0.77
  • Average True Range (ATR)
  • ADIL 0.05
  • AYRO 0.07
  • MACD
  • ADIL -0.00
  • AYRO -0.00
  • Stochastic Oscillator
  • ADIL 0.00
  • AYRO 0.00

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

About AYRO AYRO Inc.

AYRO Inc design and manufacture compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, which is the design, development, manufacturing, and sales of electric vehicles, and operates in the United States.

Share on Social Networks: